VAERS accepts reports of adverse events and reactions that occur following vaccination. Healthcare providers, vaccine manufacturers, and the public can submit reports to the system. While very important in monitoring vaccine safety, VAERS reports alone cannot be used to determine if a vaccine caused or contributed to an adverse event or illness. The reports may contain information that is incomplete, inaccurate, coincidental, or unverifiable. In large part, reports to VAERS are voluntary, which means they are subject to biases. This creates specific limitations on how the data can be used scientifically. Data from VAERS reports should always be interpreted with these limitations in mind.
The strengths of VAERS are that it is national in scope and can quickly provide an early warning of a safety problem with a vaccine. As part of CDC and FDA’s multi-system approach to post-licensure vaccine safety monitoring, VAERS is designed to rapidly detect unusual or unexpected patterns of adverse events, also known as “safety signals.” If a safety signal is found in VAERS, further studies can be done in safety systems such as the CDC’s Vaccine Safety Datalink (VSD) or the Clinical Immunization Safety Assessment (CISA) project. These systems do not have the same scientific limitations as VAERS, and can better assess health risks and possible connections between adverse events and a vaccine.
Key considerations and limitations of VAERS data:
Vaccine providers are encouraged to report any clinically significant health problem following vaccination to VAERS, whether or not they believe the vaccine was the cause.
Reports may include incomplete, inaccurate, coincidental and unverified information.
The number of reports alone cannot be interpreted or used to reach conclusions about the existence, severity, frequency, or rates of problems associated with vaccines.
VAERS data is limited to vaccine adverse event reports received between 1990 and the most recent date for which data are available.
VAERS data do not represent all known safety information for a vaccine and should be interpreted in the context of other scientific information.
VAERS data available to the public include only the initial report data to VAERS. Updated data which contains data from medical records and corrections reported during follow up are used by the government for analysis. However, for numerous reasons including data consistency, these amended data are not available to the public.
6am 10/16- shivering, 103 degree temperature, nausea, headache. 10/17- vomiting, extreme chest pain, shortness of breath, high heart rate, 104.8 temperature. Taken to a local hospital. Diagnosed with post covid 19 vaccination myocarditis with decreased cardiac function and elevated troponin which peaked at 573. Hospitalization inpatient cardiology floor at the hospital 10/18-10/10/21. Discharged with troponin levels at 170 and follow up echo and cardiology 10/28/21
Symptoms
Blood magnesium, Chest X-ray, Echocardiogram, Myocarditis, Respiratory viral panel, Body temperature increased, Chest pain, Electrocardiogram, Nausea, SARS-CoV-2 test, Brain natriuretic peptide, Chills, Full blood count, Red blood cell morphology, Troponin increased, C-reactive protein, Differential white blood cell count, Headache, Red blood cell sedimentation rate, Vomiting, Cardiac dysfunction, Dyspnoea, Heart rate increased, Renal function test
Vaccines
VAX DATE: 14 October 2021 |ONSET DATE: 16 October 2021 |DAYS TO ONSET: 2
Vaccine Type
Manufacturer
Vaccine Name
Dose
Route
Site
Lot
COVID19
PFIZERBIONTECH
COVID19 (COVID19 (PFIZER-BIONTECH))
2
IM
RECVDATE:
21 October 2021
CAGE_YR:
16
CAGE_MO:
RPT_DATE:
DIED:
DATEDIED:
L_THREAT:
Y
ER_VISIT:
HOSPITAL:
Y
HOSPDAYS:
4
X_STAY:
DISABLE:
RECOVD:
U
LAB_DATA:
High sensitivity troponin every 6-12 hours 10/18-10/21 Echocardiogram 10/18, 10/20 Ekg 10-18 Chest x-ray 10-18 CBC with differential 10/18, 10/21 Renal function panel 10/21 Magnesium 10/21 Red blood cell morphology 10/21 Westergren sedimentation rate 10/18 Respiratory virus panel 10/18 Covid-19 test 10/18 C-reactive protein 10/18 Brain natriuretic peptide 10/18
V_ADMINBY:
PVT
OTHER_MEDS:
Singular, Allegra
CUR_ILL:
None
HISTORY:
Asthma, allergies, eczema
PRIOR_VAX:
SPLTTYPE:
FORM_VERS:
2
TODAYS_DATE:
21 October 2021
BIRTH_DEFECT:
OFC_VISIT:
Y
ER_ED_VISIT:
Y
ALLERGIES:
cats, dogs, trees, grass, allergy to cold temperature
OpenVAERS is a private organization that posts publicly available CDC/FDA data of injuries reported post-vaccination. Reports are not proof of causality.